BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33717546)

  • 1. Comparative study of the loop-mediated isothermal amplification method and the QIAGEN
    Saito Y; Takahashi N; Matsui A; Michiyuki S; Yamauchi Y; Shimizu Y; Hoshi E; Sakao Y; Kawamura M
    J Thorac Dis; 2021 Feb; 13(2):743-753. PubMed ID: 33717546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loop-Mediated Isothermal Amplification as Point-of-Care Testing for
    Saito Y; Matsui A; Michiyuki S; Morooka H; Ibi T; Yamauchi Y; Takahashi N; Shimizu Y; Ikeya T; Hoshi E; Sakao Y; Kawamura M
    Micromachines (Basel); 2022 Jun; 13(6):. PubMed ID: 35744511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel loop‑mediated isothermal amplification method for efficient and robust detection of EGFR mutations.
    Horiuchi S; Saito Y; Matsui A; Takahashi N; Ikeya T; Hoshi E; Shimizu Y; Yasuda M
    Int J Oncol; 2020 Mar; 56(3):743-749. PubMed ID: 32124949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of the Therascreen® RGQ PCR kit for the detection of EGFR mutations in non-small cell lung carcinomas.
    Vallée A; Le Loupp AG; Denis MG
    Clin Chim Acta; 2014 Feb; 429():8-11. PubMed ID: 24269715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel, rapid point-of-care test for lung cancer patients to detect epidermal growth factor receptor gene mutations by using real-time droplet-PCR and fresh liquid cytology specimens.
    Asaka S; Yoshizawa A; Matsuda K; Yamaguchi A; Yamamoto H; Shiina T; Nakata R; Ogawa K; Zhang M; Honda T
    Oncol Rep; 2017 Feb; 37(2):1020-1026. PubMed ID: 27922678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of the therascreen® EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer.
    Hsiue EH; Lee JH; Lin CC; Yang JC
    Expert Rev Mol Diagn; 2016 Dec; 16(12):1251-1257. PubMed ID: 27737606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of EGFR mutations in liquid biopsy samples using allele-specific quantitative PCR: A comparative real-world evaluation of two popular diagnostic systems.
    Szpechcinski A; Bryl M; Wojcik P; Czyzewicz G; Wojda E; Rudzinski P; Duk K; Moes-Sosnowska J; Maszkowska-Kopij K; Langfort R; Barinow-Wojewodzki A; Chorostowska-Wynimko J
    Adv Med Sci; 2021 Sep; 66(2):336-342. PubMed ID: 34274564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical performance of the cobas EGFR mutation assay for Japanese non-small-cell lung cancer.
    Kimura H; Ohira T; Uchida O; Matsubayashi J; Shimizu S; Nagao T; Ikeda N; Nishio K
    Lung Cancer; 2014 Mar; 83(3):329-33. PubMed ID: 24439568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare epidermal growth factor receptor (EGFR) gene mutation in small cell lung carcinoma patients.
    Hwang CC; Hsieh TY; Yeh KY; Chen TP; Hua CC; Chang LC; Chen JR
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Sep; 166(3):274-279. PubMed ID: 35228756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive detection of EGFR mutations by cell-free loop-mediated isothermal amplification (CF-LAMP).
    Arjuna S; Venkataram R; Dechamma PN; Chakraborty G; Babu N; D'Cruz A; Hosmane GB; Chakraborty A
    Sci Rep; 2020 Oct; 10(1):17559. PubMed ID: 33067539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis.
    Westwood M; Joore M; Whiting P; van Asselt T; Ramaekers B; Armstrong N; Misso K; Severens J; Kleijnen J
    Health Technol Assess; 2014 May; 18(32):1-166. PubMed ID: 24827857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical influence of switching companion diagnostic tests for EGFR-TKs from Therascreen to Cobas v2.
    Uchibori K; Takano N; Manabe R; Tsugitomi R; Ogusu S; Tozuka T; Sakamoto H; Yoshida H; Amino Y; Ariyasu R; Kitazono S; Yanagitani N; Nishio M
    Thorac Cancer; 2021 Mar; 12(6):906-913. PubMed ID: 33528892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of epidermal growth factor receptor T790M mutation by allele-specific loop mediated isothermal amplification.
    Arjuna S; Chakraborty G; Venkataram R; Dechamma PN; Chakraborty A
    J Carcinog; 2020; 19():3. PubMed ID: 32684851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly Sensitive and Reliable Detection of EGFR Exon 19 Deletions by Droplet Digital Polymerase Chain Reaction.
    Oskina N; Oscorbin I; Khrapov E; Boyarskikh U; Subbotin D; Demidova I; Imyanitov E; Filipenko M
    Mol Diagn Ther; 2017 Oct; 21(5):555-562. PubMed ID: 28589341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. therascreen® EGFR RGQ PCR Kit: A Companion Diagnostic for Afatinib and Gefitinib in Non-Small Cell Lung Cancer.
    Syed YY
    Mol Diagn Ther; 2016 Apr; 20(2):191-8. PubMed ID: 26891729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of EGFR gene somatic mutations in tissues and plasma of patients with advanced non-small cell lung cancer].
    Brovkina OI; Gordiev MG; Toropovskiy AN; Khodyrev DS; Enikeev RF; Gusev OA; Shigapova LH; Nikitin AG
    Biomed Khim; 2016 Nov; 62(6):638-644. PubMed ID: 28026806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation comparison of 3 commercially available PCR-based KRAS mutation testing platforms.
    Adams JA; Post KM; Bilbo SA; Wang X; Sen JD; Cornwell AJ; Malek AJ; Cheng L
    Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):231-5. PubMed ID: 24614151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a locked nucleic acid based wild-type blocking PCR for the detection of EGFR exon 18/19 mutations.
    Vliegen L; Dooms C; De Kelver W; Verbeken E; Vansteenkiste J; Vandenberghe P
    Diagn Pathol; 2015 May; 10():57. PubMed ID: 26022577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.
    Li Y; Xu H; Su S; Ye J; Chen J; Jin X; Lin Q; Zhang D; Ye C; Chen C
    PLoS One; 2017; 12(8):e0183331. PubMed ID: 28829813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison study of the performance of the QIAGEN EGFR RGQ and EGFR pyro assays for mutation analysis in non-small cell lung cancer.
    Cushman-Vokoun AM; Crowley AM; Rapp SA; Greiner TC
    Am J Clin Pathol; 2013 Jul; 140(1):7-19. PubMed ID: 23765529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.